Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GLP-1
Biotech
Pfizer taps Blackstone for $1.5B to pave path to GLP-1 launch
Pfizer has secured up to $1.5 billion from Blackstone Life Sciences to fund development of its monthly GLP-1 receptor agonist.
Nick Paul Taylor
Nov 12, 2026 4:15am
Merck’s MASH hopeful efinopegdutide wins in mid-stage study
Nov 9, 2026 3:33pm
AHA: Boehringer plans 2027 survodutide submission after CV win
Nov 9, 2026 9:45am
MetaVia’s GLP-1 sheds liver fat and body weight in phase 1
Nov 5, 2026 9:52am
Fierce Healthcare
Oura expands clinical research with obesity-treatment study
Oct 29, 2026 8:00am
Ascletis’ rival to Lilly’s Foundayo hits diabetes trial goals
Oct 29, 2026 5:11am